Pneumonia Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064609
  • May 2021
  • Pharmaceuticals
  • 123 Pages
The global Pneumonia Vaccine market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Pneumonia Vaccine market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Pneumonia Vaccine market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Pneumonia Vaccine market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Pfizer, GlaxoSmithKline plc., Merck & Co., Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Pneumonia Vaccine market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Pneumonia Vaccine market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Pneumonia Vaccine market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Pneumonia Vaccine market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Pneumonia Vaccine Market:
The Pneumonia Vaccine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Pfizer, GlaxoSmithKline plc., Merck & Co., Inc.

Pneumonia Vaccine Market Segment Analysis:
By Vaccine Type
Pneumococcal Polysaccharide Vaccine
PPSV/PPV
Pneumococcal Conjugate Vaccine
PCV
Product Type
Prevnar 13
Synflorix
Pneumovax23
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others

Geographic Coverage for Pneumonia Vaccine Market:
The market research report on global Pneumonia Vaccine market offers complete analysis across various regions across the world. The Pneumonia Vaccine market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Pneumonia Vaccine market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Pneumonia Vaccine Market Value and Forecast
  • US
  • Canada
Europe Pneumonia Vaccine Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Pneumonia Vaccine Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Pneumonia Vaccine Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Pneumonia Vaccine Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Pneumonia Vaccine market report:
  • The report provides key trends of the global Pneumonia Vaccine market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Pneumonia Vaccine industry
  • The report covers all the recent developments of the Pneumonia Vaccine market and helps to provide current industry updates
  • The report covers a detailed look over the global Pneumonia Vaccine Industry and provides with significant actionable insights
  • The Pneumonia Vaccine market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Pneumonia Vaccine market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Pneumonia Vaccine market
  • Comprehensive analysis of the Pneumonia Vaccine market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Pneumonia Vaccine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Pneumonia Vaccine market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Pneumonia Vaccine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Pneumonia Vaccine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Pneumonia Vaccine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Pneumonia Vaccine Market Snapshot
          2.1.1. Global Pneumonia Vaccine Market By Vaccine Type,2019
               2.1.1.1.Pneumococcal Polysaccharide Vaccine
               2.1.1.2.PPSV/PPV
          2.1.2. Global Pneumonia Vaccine Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Others
          2.1.3. Global Pneumonia Vaccine Market By End-use,2019
          2.1.4. Global Pneumonia Vaccine Market By Geography,2019

3. Global Pneumonia Vaccine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Vaccine Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Vaccine Type, 2020
     4.2. Global Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028

5. Global Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028

7. Global Pneumonia Vaccine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Pneumonia Vaccine Market Analysis, 2018 – 2028 
          7.2.1. North America Pneumonia Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028
          7.2.3. North America Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Pneumonia Vaccine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Pneumonia Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028
          7.3.3. Europe Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Pneumonia Vaccine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Pneumonia Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028
          7.4.3. Asia Pacific Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Pneumonia Vaccine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Pneumonia Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028
          7.5.3. Latin America Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Pneumonia Vaccine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Pneumonia Vaccine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Pneumonia Vaccine Market Size (US$), By Vaccine Type, 2018 – 2028
          7.6.3. MEA Pneumonia Vaccine Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Pneumonia Vaccine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Pneumonia Vaccine Providers
        8.4.1 Pfizer
                8.4.1.1 Business Description
                8.4.1.2 Pfizer Geographic Operations
                8.4.1.3 Pfizer Financial Information
                8.4.1.4 Pfizer Product Positions/Portfolio
                8.4.1.5 Pfizer Key Developments
        8.4.2 GlaxoSmithKline plc.
                8.4.2.1 Business Description
                8.4.2.2 GlaxoSmithKline plc. Geographic Operations
                8.4.2.3 GlaxoSmithKline plc. Financial Information
                8.4.2.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.2.5 GlaxoSmithKline plc. Key Developments
        8.4.3 Merck & Co., Inc.
                8.4.3.1 Business Description
                8.4.3.2 Merck & Co., Inc. Geographic Operations
                8.4.3.3 Merck & Co., Inc. Financial Information
                8.4.3.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.3.5 Merck & Co., Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Pneumonia Vaccine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Pneumonia Vaccine Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Pneumonia Vaccine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Pneumonia Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Pneumonia Vaccine Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Pneumonia Vaccine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Pneumonia Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Pneumonia Vaccine Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Pneumonia Vaccine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Pneumonia Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Pneumonia Vaccine Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Pneumonia Vaccine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Pneumonia Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Pneumonia Vaccine Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Pneumonia Vaccine Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Pneumonia Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Pneumonia Vaccine: Market Segmentation 
FIG. 2 Global Pneumonia Vaccine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Pneumonia Vaccine Market, By Vaccine Type, 2019 (US$ Mn) 
FIG. 5 Global Pneumonia Vaccine Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Pneumonia Vaccine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Pneumonia Vaccine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Pneumonia Vaccine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Pneumonia Vaccine Providers, 2019
FIG. 11 Global Pneumonia Vaccine Market Revenue Contribution, By Vaccine Type, 2019 & 2028 (Value %) 
FIG. 12 Global Pneumonia Vaccine Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Pneumonia Vaccine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Pneumonia Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Pneumonia Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Pneumonia Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Pneumonia Vaccine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Pneumonia Vaccine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Pneumonia Vaccine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Pneumonia Vaccine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Pneumonia Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  North America Pneumonia Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  North America Pneumonia Vaccine Market Value, By Country, 2018 – 2028
TABLE  Europe Pneumonia Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Pneumonia Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Pneumonia Vaccine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Pneumonia Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Pneumonia Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Pneumonia Vaccine Market Value, By Country, 2018 – 2028
TABLE  Latin America Pneumonia Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Pneumonia Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Pneumonia Vaccine Market Value, By Country, 2018 – 2028
TABLE  MEA Pneumonia Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Pneumonia Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Pneumonia Vaccine Market Value, By Country, 2018 – 2028
TABLE  Pfizer: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Pneumonia Vaccine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Pneumonia Vaccine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Pneumonia Vaccine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Pneumonia Vaccine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Pneumonia Vaccine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Pneumonia Vaccine Providers, 2016
FIG.  Global Pneumonia Vaccine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global PPSV/PPV Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pneumonia Vaccine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Pneumonia Vaccine Market Value, 2018 – 2028, (US$ Mn)